A personalized window into pregnancy health
Mirvie is a women's health company that has developed a proprietary RNA platform to predict pregnancy complications months before symptoms appear using a simple blood draw. The platform analyzes tens of thousands of RNA messages from the baby, placenta, and mother, combining them with machine learning to identify risk for conditions like preeclampsia and preterm birth. Its Encompass test for preeclampsia received clinical validation in studies published in Nature and other peer-reviewed journals.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountAug 2025
Aug 2023
May 2022
Apr 2021
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Global biosimulation software and services company accelerating drug development for 2,000+ bioph...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
